Comorbid Conditions in Neonates With Congenital Heart Disease

Ganga Krishnamurthy1, Veniamin Ratner, Emile Bacha

  • 11Department of Pediatrics, Section of Neonatology and Perinatology, Neonatal Cardiac Care, Columbia University College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY. 2Department of Pediatrics, Section of Neonatology and Perinatology, Columbia University College of Physicians and Surgeons, New York- Presbyterian Morgan Stanley Children's Hospital, New York, NY. 3Department of Surgery, Congenital and Pediatric Cardiac Surgery, Columbia University College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY. 4Department of Surgery, Columbia University College of Physicians and Surgeons, New York-Presbyterian Morgan Stanley Children's Hospital, New York, NY.

Insights

Infants with congenital heart disease and noncardiac anomalies face higher mortality risks. Optimal outcomes require a collaborative, interdisciplinary approach for these complex cases.

Area of Science:

  • Pediatric Cardiology
  • Neonatology
  • Medical Genetics

Background:

  • Congenital heart disease (CHD) significantly increases mortality risk when associated with noncardiac anomalies.
  • Prematurity in infants with CHD presents unique challenges due to immature organ systems.
  • Management of these complex cases requires specialized, coordinated care.

Purpose of the Study:

  • To review the pathophysiology of major noncardiac anomalies in infants with CHD.
  • To discuss the clinical impact of these anomalies and prematurity on infants with CHD.
  • To outline current treatment strategies for these complex pediatric cases.

Main Methods:

  • Literature review of MEDLINE and PubMed databases.
  • Synthesis of information on pathophysiology, clinical impact, and treatment.
  • Focus on major noncardiac anomalies and prematurity in the context of CHD.

Main Results:

  • Noncardiac anomalies significantly elevate mortality in infants with CHD.
  • Several noncardiac anomalies necessitate neonatal surgery for survival.
  • Premature infants with CHD experience compounded physiological challenges.

Conclusions:

  • A collaborative, interdisciplinary approach is essential for optimal outcomes in premature infants and those with multiple congenital anomalies.
  • Effective management hinges on addressing both cardiac and noncardiac issues.
  • Early and coordinated interventions improve survival and quality of life.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.1K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
716
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
863
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
781